Xiaofeng D. and colleagues classified 84 BC cell lines based on the status of the ER, PR, and HER2 into five subgroups, i.e., luminal A, luminal B, HER2 positive, and basal A, and B, to overcome the inconsistent nomenclature and facilitate BC modeling using appropriate cell lines [18]. This evidence concerns the gene ERBB2 and breast cancer.